WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot
CAPE TOWN, Sept 14 (Reuters) - Efforts to develop an African base for COVID-19 vaccine production will focus on trying to replicate Moderna's (MRNA.O) shot, but a lack of progress in talks with the U.S. company mean the project will take time, a senior WHO official told Reuters.
The drive to produce vaccines in Africa is designed to help more developing countries access COVID-19 shots after rich nations bought up most of this year's supply.